Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence

The Readout Loud - A podcast by STAT - Thursdays

Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does "folie à deux" mean?